SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-002082
Filing Date
2024-01-08
Accepted
2024-01-08 08:28:15
Documents
6
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 6-K tm242354d1_6k.htm 6-K 9080
2 EXHIBIT 99.1 tm242354d1_ex99-1.htm EX-99.1 16890
3 EXHIBIT 99.2 tm242354d1_ex99-2.htm EX-99.2 15193
4 GRAPHIC image_001.jpg GRAPHIC 2718
5 GRAPHIC tm242354d1_ex99-2img001.jpg GRAPHIC 2264
6 GRAPHIC tm242354d1_ex99-2img002.jpg GRAPHIC 2145
  Complete submission text file 0001104659-24-002082.txt   52476
Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39308 | Film No.: 24518481
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)